IQVIA Holdings Q3FY26 Results: Earnings call scheduled for Oct 27
- IQVIA Holdings Inc. will announce third-quarter 2026 financial results on October 27, 2026
- Conference call and webcast scheduled for 9:00 am Eastern Time on the same day
- Earnings release and financial information will be posted on the Investor Relations website
- Webcast replay available approximately two hours after the live event concludes

*this image is generated using AI for illustrative purposes only.
IQVIA Holdings Inc. (NYSE: IQV) will announce its third-quarter 2026 financial results before the market opens on Tuesday, October 27, 2026. The global provider of clinical research services and healthcare intelligence has scheduled a management conference call for the same day.
The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website. Investors and analysts can access the presentation slides and webcast via the company’s investor portal.
Conference Call Details
The IQVIA management team will host a conference call and webcast at 9:00 am Eastern Time on October 27, 2026. Participants must register in advance through the Investor Relations website to receive a confirmation email containing dial-in details, a unique passcode, and a registrant ID.
A replay of the webcast will be available approximately two hours after the conclusion of the live event. The recording can be accessed via the IQVIA Investor Relations website.
Company Profile
IQVIA is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company employs approximately 94,000 people in over 100 countries.
IQVIA’s solutions are powered by IQVIA Connected Intelligence™, leveraging high-quality health data, Healthcare-grade AI®, advanced analytics, and domain expertise. The company emphasizes responsible AI use with capabilities built on privacy, regulatory compliance, and patient safety standards.
How might IQVIA's Q3 2026 earnings guidance influence the broader CRO sector's valuation multiples for the remainder of the fiscal year?
What specific metrics regarding Healthcare-grade AI® adoption will management highlight to demonstrate ROI on their Connected Intelligence™ platform?
Given the global workforce of 94,000, how are labor cost trends and wage inflation in key markets impacting IQVIA's operating margins?































